Results 271 to 280 of about 541,619 (302)
Some of the next articles are maybe not open access.
Anti-interleukin-12 and anti-interleukin-23 agents in Crohn’s disease
Expert Opinion on Biological Therapy, 2018Blockers of IL-12/23, as well as specific blockers of IL-23, have been investigated as options for medical therapy in inflammatory bowel disease. These biological agents include ustekinumab - the first agent of this pharmacological class which has shown clinical efficacy in psoriasis, psoriatic arthritis, and moderate-to-severe Crohn's disease (CD ...
Fabio Salvatore, Macaluso +2 more
openaire +2 more sources
Spondyloarthropathy: interleukin 23 and disease modification
The Lancet, 2015Jonathan P, Sherlock +3 more
openaire +2 more sources
Interleukin-17 and interleukin-23 regulate Langerhans cell migration
British Journal of Dermatology, 2016Eaton, L H +3 more
openaire +3 more sources
Interleukin-22: Immunobiology and Pathology
Annual Review of Immunology, 2015Jarrod A Dudakov, Alan M Hanash
exaly
Historical overview of the interleukin-6 family cytokine
Journal of Experimental Medicine, 2020Sujin Kang +2 more
exaly
Signaling and Function of Interleukin-2 in T Lymphocytes
Annual Review of Immunology, 2018Sarah H Ross, Doreen A Cantrell
exaly
Interleukin 6 Is Required for the Development of Collagen-induced Arthritis
Journal of Experimental Medicine, 1998Tonino Alonzi +2 more
exaly